Through seven key considerations, this paper explores the IM regulations and challenges to be tackled from the perspective of a collateral management and OTC derivatives operations leader. It is designed to help the reader understand what to consider, within a specific timeframe, and how to meet their compliance date across the areas of law, risk, operations and technology.
- Have you allowed enough time?
- Are you in scope?
- Have you understood the operational impact of exchanging IM?
- Have you considered the many implementation approaches?
- How will your firm calculate IM?
- Have you selected a custodian or triparty agent?
- Have you begun work on the legal documentation?